Occupational exposure to organic solvents: A risk factor for pulmonary veno-occlusive disease

European Respiratory Journal

Volumn 46, Issue 6, 2015, Pages 1721-1731

  Montani, David ^a,b,c   Lau, Edmund M ^a,b,c   Descatha, Alexis ^d   Jaïs, Xavier ^a,b,c   Savale, Laurent ^a,b,c   Andujar, Pascal ^e   Bensefa Colas, Lynda ^f   Girerd, Barbara ^a,b,c   Zendah, Inès ^g   Le Pavec, Jerome ^h   Seferian, Andrei ^a,b,c   Perros, Frédéric ^a,b,c   Dorfmüller, Peter ^a,c,h   Fadel, Elie ^a,c,h   Soubrier, Florent ⁱ   Sitbon, Oliver ^a,b,c   Simonneau, Gérald ^a,b,c   Humbert, Marc ^a,b,c  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b BICÊTRE HOSPITAL   (France)

^c Universite Paris Sud   (France)

^d UMS 011   (France)

^e CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^f AP HP   (France)

^g ABDERRAHMAN MAMI HOSPITAL   (Tunisia)

^h CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

ⁱ Sorbonne Universités   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BMPR2 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; EIF2AK4 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; SOLVENT; TRICHLOROETHYLENE;

ADULT; AGED; CASE CONTROL STUDY; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; HYPERTENSION, PULMONARY; LUNG; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OCCUPATIONAL EXPOSURE; ONSET AGE; PATHOLOGY; PULMONARY VENO-OCCLUSIVE DISEASE; QUESTIONNAIRE; RISK FACTOR; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; YOUNG ADULT;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; CASE-CONTROL STUDIES; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION, PULMONARY; LOGISTIC MODELS; LUNG; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OCCUPATIONAL EXPOSURE; PROTEIN-SERINE-THREONINE KINASES; PULMONARY VENO-OCCLUSIVE DISEASE; RISK FACTORS; SOLVENTS; SURVEYS AND QUESTIONNAIRES; TRICHLOROETHYLENE; YOUNG ADULT;

EID: 84948968052     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.00814-2015     Document Type: Article

References (37)

1. Montani D, Price LC, Dorfmuller P, et al. Pulmonary veno-occlusive disease. Eur Respir J 2009; 33: 189-200.
2. Pietra GG, Capron F, Stewart S, et al. Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol 2004; 43: 25S-32S.
3. Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013; 62: D34-D41.
4. Lantuejoul S, Sheppard MN, Corrin B, et al. Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis: a clinicopathologic study of 35 cases. Am J Surgical Pathol 2006; 30: 850-857.
5. Eyries M, Montani D, Girerd B, et al. EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension. Nature Genet 2014; 46: 65-69.
6. Best DH, Sumner KL, Austin ED, et al. EIF2AK4 mutations in pulmonary capillary hemangiomatosis. Chest 2014; 145: 231-236.
7. Galie N, Humbert M, Vachiery J-L, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2015; 46: 903-975.
8. Montani D, Achouh L, Dorfmuller P, et al. Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology. Medicine 2008; 87: 220-233.
9. Ranchoux B, Gunther S, Quarck R, et al. Chemotherapy-induced pulmonary hypertension: role of alkylating agents. Am J Pathol 2015; 185: 356-371.
10. Perros F, Gunther S, Ranchoux B, et al. Mitomycin-induced pulmonary veno-occlusive disease: evidence from human disease and animal models. Circulation 2015; 132: 834-847.
11. Mandel J, Mark EJ, Hales CA. Pulmonary veno-occlusive disease. Am J Respir Crit Care Med 2000; 162: 1964-1973.
12. Johnson SR, Patsios D, Hwang DM, et al. Pulmonary veno-occlusive disease and scleroderma associated pulmonary hypertension. J Rheum 2006; 33: 2347-2350.
13. Dorfmuller P, Humbert M, Perros F, et al. Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases. Humam Pathol 2007; 38: 893-902.
14. Gunther S, Jais X, Maitre S, et al. Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertension. Arthritis Rheum 2012; 64: 2995-3005.
15. Marie I, Gehanno JF, Bubenheim M, et al. Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature. Autoimmun Rev 2014; 13: 151-156.
16. Nietert PJ, Sutherland SE, Silver RM, et al. Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheum 1998; 41: 1111-1118.
17. Barragan-Martinez C, Speck-Hernandez CA, Montoya-Ortiz G, et al. Organic solvents as risk factor for autoimmune diseases: a systematic review and meta-analysis. PloS One 2012; 7: e51506.
18. Hoeper MM, Bogaard HJ, Condliffe R, et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol 2013; 62: D42-D50.
19. Girerd B, Montani D, Coulet F, et al. Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRLl1 (ALK1) mutation. Am J Respir Crit Care Med 2010; 181: 851-861.
20. Févotte J, Dananché B, Delabre L, et al. Matgéné: a program to develop job-exposure matrices in the general population in france. Ann Occup Hyg 2011; 55: 865-878.
21. Institut de Veille Sanitaire. Exp-pro: Outils d'aide ? l'évaluation des expositions professionnelles [Exp-pro: tools for the evaluation of occupational exposures]. http://exppro.invs.sante.fr/exppro/accueil. Date last accessed: March 15, 2015.
22. Bourgkard E, Wild P, Gonzalez M, et al. Comparison of exposure assessment methods in a lung cancer case-control study: performance of a lifelong task-based questionnaire for asbestos and PAHs. Occup Environ Med 2013; 70: 884-891.
23. Offermans NS, Vermeulen R, Burdorf A, et al. Comparison of expert and job-exposure matrix-based retrospective exposure assessment of occupational carcinogens in the Netherlands cohort study. Occup Environ Med 2012; 69: 745-751.
24. Baker EL. A review of recent research on health effects of human occupational exposure to organic solvents. A critical review. J Occup Med 1994; 36: 1079-1092.
25. Ruder AM, Yiin JH, Waters MA, et al. The upper midwest health study: gliomas and occupational exposure to chlorinated solvents. Occup Environ Med 2013; 70: 73-80.
26. Mattei F, Guida F, Matrat M, et al. Exposure to chlorinated solvents and lung cancer: results of the ICARE study. Occup Environ Med 2014; 71: 681-689.
27. Kettaneh A, Al Moufti O, Tiev KP, et al. Occupational exposure to solvents and gender-related risk of systemic sclerosis: a metaanalysis of case-control studies. J Rheum 2007; 34: 97-103.
28. Hachulla E, Gressin V, Guillevin L, et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 2005; 53: 3792-3800.
29. Ou Z, McCarver DG, Hines RN, et al. Trichloroethylene decreases heat shock protein 90 interactions with endothelial nitric oxide synthase: implications for endothelial cell proliferation. Toxicol Sci 2003; 73: 90-97.
30. Donnelly N, Gorman AM, Gupta S, et al. The EIF2alpha kinases: their structures and functions. Cell Mol Life Sci 2013; 70: 3493-3511.
31. Arriazu E, Ruiz de Galarreta M, Lopez-Zabalza MJ, et al. GCN2 kinase is a key regulator of fibrogenesis and acute and chronic liver injury induced by carbon tetrachloride in mice. Lab Invest 2013; 93: 303-310.
32. Chaveroux C, Lambert-Langlais S, Parry L, et al. Identification of GCN2 as new redox regulator for oxidative stress prevention in vivo. Biochem Biophys Res 2011; 415: 120-124.
33. Arriazu E, Perez de Obanos MP, Lopez-Zabalza MJ, et al. Amino acid deprivation decreases intracellular levels of reactive oxygen species in hepatic stellate cells. Cell Physiol Biochem 2010; 26: 281-290.
34. Giovanetti A, Rossi L, Mancuso M, et al. Analysis of lung damage induced by trichloroethylene inhalation in mice fed diets with low, normal, and high copper content. Toxicol Pathol 1998; 26: 628-635.
35. Dorfmuller P, Chaumais MC, Giannakouli M, et al. Increased oxidative stress and severe arterial remodeling induced by permanent high-flow challenge in experimental pulmonary hypertension. Respir Res 2011; 12: 119.
36. Fortuno A, San Jose G, Moreno MU, et al. Oxidative stress and vascular remodelling. Exp Physiol 2005; 90: 457-462.
37. Lipscomb JC, Garrett CM, Snawder JE. Cytochrome P450-dependent metabolism of trichloroethylene: interindividual differences in humans. Toxicol Appl Pharmacol 1997; 142: 311-318.